Spots Global Cancer Trial Database for Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
Official Title: Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
Study ID: NCT06199115
Conditions
Interventions
Study Description
Brief Summary: Peripheral neuropathy is one of the most common side effects of oxaliplatin (OXA)-based chemotherapy for patients treated for digestive cancers, disabling and dose-limiting. Several strategies have been studied for the treatment of oxaliplatin-related sensory neuropathy. Several pharmacological and non-pharmacological therapeutic strategies have been explored to relieve peripheral neuropathic pain. Non-pharmacological interventions have been shown to be potentially beneficial for patients suffering from chemotherapy-induced neurotoxicity. The objective of this prospective study is to evaluate the effectiveness of photobiomodulation on the reduction of neuropathic pain in patients who developed painful, cumulative peripheral neuropathy that appeared under the effect of the treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHP Saint-Grégoire, Saint-Grégoire, , France
Contact Details
Name: Morgane Pihan
Affiliation: CHP Saint-Grégoire
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
